Literature DB >> 15575844

Patient demographics and utilization of health care services for molluscum contagiosum.

Arlene C Molino1, Alan B Fleischer, Steven R Feldman.   

Abstract

Our objective was to describe the demographics of molluscum contagiosum patients and physician utilization patterns in the United States. We obtained weighted data for office visits throughout the United States for molluscum contagiosum and common warts from the National Ambulatory Medical Care Survey (NAMCS) from 1990 to 1999. Outpatient visit data for patients diagnosed with molluscum contagiosum were analyzed using statistical software and compared to those for patients diagnosed with common warts. The main outcome measures studied were physician office visits by patients with molluscum contagiosum and patient demographic parameters including age, gender, and race. We found that health care utilization for molluscum contagiosum was the greatest for patients <or=9 years of age (51%). Ninety-three percent of patients diagnosed with molluscum contagiosum were white. The number of visits for molluscum contagiosum was evenly divided between males and females. Visits to dermatologists comprised the majority of health care utilization units for molluscum contagiosum (71%). In conclusion, visits for molluscum contagiosum are frequent and are most often handled by dermatologists. When compared to those for common warts, molluscum contagiosum visits are less common and have an age distribution more limited to children.

Entities:  

Mesh:

Year:  2004        PMID: 15575844     DOI: 10.1111/j.0736-8046.2004.21602.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  7 in total

1.  The poxvirus A35 protein is an immunoregulator.

Authors:  Kristina E Rehm; Gwendolyn J B Jones; Alice A Tripp; Mark W Metcalf; Rachel L Roper
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

Review 2.  National athletic trainers' association position statement: skin diseases.

Authors:  Steven M Zinder; Rodney S W Basler; Jack Foley; Chris Scarlata; David B Vasily
Journal:  J Athl Train       Date:  2010 Jul-Aug       Impact factor: 2.860

Review 3.  Interventions for cutaneous molluscum contagiosum.

Authors:  Johannes C van der Wouden; Renske van der Sande; Emma J Kruithof; Annet Sollie; Lisette Wa van Suijlekom-Smit; Sander Koning
Journal:  Cochrane Database Syst Rev       Date:  2017-05-17

4.  Vaccinia virus A35R inhibits MHC class II antigen presentation.

Authors:  Kristina E Rehm; Ramsey F Connor; Gwendolyn J B Jones; Kenneth Yimbu; Rachel L Roper
Journal:  Virology       Date:  2009-12-02       Impact factor: 3.616

5.  Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II.

Authors:  Kristina E Rehm; Ramsey F Connor; Gwendolyn J B Jones; Kenneth Yimbu; Mark D Mannie; Rachel L Roper
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

6.  The Incidence of Molluscum contagiosum among American Indians and Alaska Natives.

Authors:  Mary G Reynolds; Robert C Holman; Krista L Yorita Christensen; James E Cheek; Inger K Damon
Journal:  PLoS One       Date:  2009-04-21       Impact factor: 3.240

7.  Molluscum contagiosum in a pediatric American Indian population: incidence and risk factors.

Authors:  Andrea M McCollum; Robert C Holman; Christine M Hughes; Jason M Mehal; Arianne M Folkema; John T Redd; James E Cheek; Inger K Damon; Mary G Reynolds
Journal:  PLoS One       Date:  2014-07-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.